Page last updated: 2024-11-05

thalidomide and Food Hypersensitivity

thalidomide has been researched along with Food Hypersensitivity in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Food Hypersensitivity: Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens in food.

Research Excerpts

ExcerptRelevanceReference
"Levamisole has shown variable efficacy in reducing ulcer frequency and duration in patients with minor RAU."2.41Treatment strategies for recurrent oral aphthous ulcers. ( Barrons, RW, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fraser, K1
Barrons, RW1

Reviews

1 review available for thalidomide and Food Hypersensitivity

ArticleYear
Treatment strategies for recurrent oral aphthous ulcers.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Jan-01, Volume: 58, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Topical; Adrenal Cortex Hormones; Aminopyridines; Anti-Infla

2001

Other Studies

1 other study available for thalidomide and Food Hypersensitivity

ArticleYear
72nd annual meeting of the American Academy of Dermatology.
    American journal of clinical dermatology, 2014, Volume: 15, Issue:2

    Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins,

2014